The Opioid Epidemic
JBS: Breaking New Ground at Every Touchpoint
SUBSTANCE ABUSE AMONG OLDER ADULTS: An Emerging Public Health Crisis
A webinar series brought to you by SAMHSA's State TA Project
View information on past and upcoming webinars in the series.
Industry-Recognized Experts
Since our beginning, JBS has worked on the frontlines of every major drug epidemic that has plagued the U.S., including crack cocaine, club drugs, inhalants, steroids, and crystal meth — and most recently, the skyrocketing misuse of prescription opioids and heroin.
CME Trainings for Health Providers
JBS has created curricula for a range of specialized audiences, from first responders to pharmacists to family members to prisoner re-entry programs. We designed a continuing medical education (CME) program completed by more than 26,500 clinicians to date through a technical assistance project.
Download Our OPIOID brochure
The abuse of opioids such as heroin, morphine, and prescription pain relievers has led to devastating effects on the health and social welfare of nearly every demographic in American society. JBS’s staff has deep expertise on every touchpoint surrounding this vitally important issue. Download our brochure to learn more.
Healthcare/Workforce Development
Technology has become increasingly important to the efficiency of medical practices. The landscape is becoming more patient-centered, featuring a range of technologies capable of remotely monitoring patients’ physical and emotional states.
Improved Access to Care
We deliver technical assistance by identifying what's working and in what environments. By disseminating that knowledge and information to individuals, programs, and providers, we’re able to ensure everybody has access to the same type of information that will deliver the best care to the vulnerable populations in need. Since the opioid epidemic exploded, so too have treatment options.
Understanding of Medications to Treat Opioid Use Disorder
Treating opioid use disorder (OUD) with medications and behavioral health support offers opioid-dependent patients a path toward recovery. While medications do not cure addiction, they lessen the cravings and withdrawal symptoms and therefore provide the opportunity for individuals to get back on track and maintain their recovery over time.
Sign Up for JBS Opioid Updates
Integration of Primary Care & Behavioral Health
JBS has had a unique role in facilitating the integration of primary care and behavioral health. The opioid epidemic presented an opportunity for the two fields to collaborate and improve the quality of treatment.
Experience with Vulnerable Populations
Our substance abuse work — particularly in opioids — cuts across many vulnerable populations including pregnant, postpartum and parenting women, people involved with the criminal justice system, adolescents, patients with comorbidities such as mental health issues, and rural and urban communities with limited access to care.
Hear What Our Experts Have To Say
The Opioid Epidemic Ravaging America
Download the infographic to learn about the many ways U.S. communities are impacted by or involved in the opioid epidemic.
Experts For Your Project
-
Pamela BastonTechnical Expert Lead -
Joyce DampeerCorporate Monitor & Senior Principal -
Susan HayashiVice President/Project Director -
Joseph HydeTechnical Expert Lead -
Jennifer KastenChief Strategy Officer -
Kathleen MeyersTechnical Expert Lead -
Joseph PerpichSenior Medical Advisor -
John RobertsSenior Technical Assistance Manager -
Larry RobertsonVice President/Project Director -
Kimberly WalshTechnical Expert Lead -
David WanserSenior Policy Advisor -
Aldrenna WilliamsTechnical Expert Lead
Work Samples
-
SSA - SBIRT Services in Healthcare SettingsVisit Website -
Expanding Access to CareDownload pdf -
Naloxone CE for PharmacistsVisit Website -
NIDA CoE Curriculum OverviewVisit Website -
MAT - PDOA Fact SheetDownload pdf -
Case Study: Learning From and Supporting Clinicians in the FieldDownload pdf -
Helping Our Most Vulnerable Populations Impacted by the Opioid CrisisDownload pdf
Take A Deeper Look at What Sets Us Apart
Below is a sampling of JBS’s opioids-related projects:
CME/CE Training for Healthcare Providers
- Prescription medication misuse, abuse, overdose, safe prescribing, and medication-assisted treatment (MAT) – trained more than 104,000 medical professionals
- Clinical Challenges in Opioid Prescribing: Balancing Safety and Efficacy – 7 publications
- NIDA Adolescent Substance Use and Rx Medication Misuse CME/CE – trained 14,000 healthcare workers and issued 5,000 CMEs/CEs
- TA to support Drug Addiction Treatment Act of 2000-waivered physician trainings – 11 onsite TA events
- Naloxone Overdose Prevention and Education Program
- MAT Regional Training: Drug Court and MAT Successes – trained 18 clinicians
Healthcare Workforce Development
- Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants
- "Opioid Use Disorders (OUD): What Pediatricians Should Know" publication
- Small, regional trainings with medical professionals to provide training to fight the opioid epidemic and opioid use disorder
- State TA prescriber guidelines (PA)
- Support OTP accreditation/certification and conduct medical education training in eight states per year
Improved Access to Care
- Online course: Overcoming Barriers to Prescribing Buprenorphine
- Sustainability planning for State of Hawaii
- TA to expand MAT through mobile services (in CO, DC, NV, OK, and PR)
- Multi-state meetings on Expanding Access and Opioid-Related Overdose Policies and Practices
Integration of Primary Care and Behavioral Health
- SAMHSA Buprenorphine Summit, MAT and Benzodiazepine Meeting, and a U.S. Department of Health and Human Services Tele-Substance Use Treatment Working Group resulting in Guide for Policy Change
- Outreach and Education to Healthcare Providers on Substance Use – 12 Curriculum Resources
Outreach to Vulnerable Populations
- Development and implementation of face-to- face and virtual training modules for use with child welfare professionals and family court judicial staff including opioid-specific toolkits, child welfare motivational interviewing scripts, child welfare supervision learning activities, and a judicial bench guide
- Journal of Addiction Medicine publication (2017): "Treating women who are pregnant and postpartum for opioid use disorders and the concurrent care of their infants and children: Literature review to support national guidance"
- Webinar: MAT in Correctional Settings
Training and Technical Assistance for Treating OUD with Medications and Recovery Support
- Social marketing campaigns to overcome resistance to MAT (in GA, KY, NY, OK, and VT)
- TA to strengthen clinical and management systems of 28 state grantees that include 95 individual MAT providers
Program Evaluation
- Treatment Programs and Services for Pregnant and Postpartum Women: A Program Evaluation demonstrating lack of coordinated MAT services for PPW residents
- State TA on data collection for prevention of non-medical use of prescription opioids (in NM)
